Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:222
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [31] UMOD as a susceptibility gene for end-stage renal disease
    Reznichenko, Anna
    Boeger, Carsten A.
    Snieder, Harold
    van den Born, Jacob
    de Borst, Martin H.
    Damman, Jeffrey
    van Dijk, Marcory C. R. F.
    van Goor, Harry
    Hepkema, Bouke G.
    Hillebrands, Jan-Luuk
    Leuvenink, Henri G. D.
    Niesing, Jan
    Bakker, Stephan J. L.
    Seelen, Marc
    Navis, Gerjan
    BMC MEDICAL GENETICS, 2012, 13
  • [32] Predictors of End-stage Renal Disease in the Urban Poor
    Hall, Yoshio N.
    Choi, Andy I.
    Xu, Ping
    Smith, Nicholas L.
    Boyko, Edward J.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2013, 24 (04) : 1686 - 1700
  • [33] Cardiovascular risk in children and adolescents with end stage renal disease
    do Val, Maria Luiza
    Menezes, Fernanda Souza
    Massaoka, Henrique Tsuha
    Scavarda, Valeska Tavares
    Czapkowski, Adriano
    Leite, Heitor Pons
    Moises, Valdir Ambrosio
    Ajzen, Sergio Aron
    de Abreu Carvalhaes, Joao Tomas
    Medina Pestana, Jose Osmar
    Koch-Nogueira, Paulo
    CLINICS, 2019, 74
  • [34] Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis
    Lee, Jia-Jung
    Lin, Ming-Yen
    Chang, Jung-San
    Hung, Chi-Chih
    Chang, Jer-Ming
    Chen, Hung-Chun
    Yu, Ming-Lung
    Hwang, Shang-Jyh
    PLOS ONE, 2014, 9 (06):
  • [35] End-stage renal disease among Roma and non-Roma: Roma are at risk
    Kolvek, Gabriel
    Rosicova, Katarina
    Rosenberger, Jaroslav
    Podracka, Ludmila
    Stewart, Roy E.
    Nagyova, Iveta
    Reijneveld, Sijmen A.
    van Dijk, Jitse P.
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2012, 57 (04) : 751 - 754
  • [36] Dialyzer Reuse and Mortality Risk in Patients with End-Stage Renal Disease: A Systematic Review
    Galvao, Tais Freire
    Silva, Marcus Tolentino
    de Almeida Araujo, Maria Elizete
    Bulbol, Wilson Seffair
    de Melo Pereira Cardoso, Angela Libia
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (03) : 249 - 258
  • [37] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Dalrymple, Lorien S.
    Katz, Ronit
    Kestenbaum, Bryan
    Shlipak, Michael G.
    Sarnak, Mark J.
    Stehman-Breen, Catherine
    Seliger, Stephen
    Siscovick, David
    Newman, Anne B.
    Fried, Linda
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (04) : 379 - 385
  • [38] Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease
    Lee, Jangwook
    Choe, Hye Rim
    Park, Sang Hyun
    Do Han, Kyung
    Kim, Dong Ki
    Joo, Kwon Wook
    Kim, Yon Su
    Lee, Eun Kyoung
    Park, Un Chul
    Yu, Hyeong Gon
    Lee, Hajeong
    Kim, Yong Chul
    Oh, Baek-Lok
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Mortality risk in European children with end-stage renal disease on dialysis
    Chesnaye, Nicholas C.
    Schaefer, Franz
    Groothoff, Jaap W.
    Bonthuis, Marjolein
    Reusz, Gyorgy
    Heaf, James G.
    Lewis, Malcolm
    Maurer, Elisabeth
    Paripovic, Dusan
    Zagozdzon, Ilona
    van Stralen, Karlijn J.
    Jager, Kitty J.
    KIDNEY INTERNATIONAL, 2016, 89 (06) : 1355 - 1362
  • [40] Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure
    Hwang, Jyh-Chang
    Jiang, Ming-Yan
    Lu, Yi-Hua
    Weng, Shih-Feng
    MEDICINE, 2016, 95 (03)